ArticlePharmaceutics2020

Oral Administration System Based on Meloxicam Nanocrystals: Decreased Dose Due to High Bioavailability Attenuates Risk of Gastrointestinal Side Effects.

Noriaki Nagai et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.